AAPL349.52+5.69 (+1.65%) ▲|ABBV291.18+5.19 (+1.81%) ▲|ABT103.62+0.98 (+0.95%) ▲|ACN243.66+0.26 (+0.10%) ▲|ADBE247.70-2.06 (-0.82%) ▼|AMAT416.25+0.25 (+0.06%) ▲|AMD568.12-10.32 (-1.78%) ▼|AMGN465.24+13.41 (+2.97%) ▲|AMT185.10+1.35 (+0.73%) ▲|AMZN246.26-8.34 (-3.28%) ▼|AVGO342.50-9.32 (-2.65%) ▼|AXP325.34+7.40 (+2.33%) ▲|BA170.33+3.19 (+1.91%) ▲|BAC51.76+0.91 (+1.78%) ▲|BKNG151.34+3.40 (+2.30%) ▲|BLK1,175.81+17.93 (+1.55%) ▲|BMY60.30-0.27 (-0.45%) ▼|BNY149.42+0.83 (+0.56%) ▲|BRK-B544.87+4.53 (+0.84%) ▲|C126.14+2.03 (+1.64%) ▲|CAT660.01-53.38 (-7.48%) ▼|CL91.89+0.20 (+0.21%) ▲|CMCSA21.82+0.25 (+1.16%) ▲|COF208.56+3.68 (+1.80%) ▲|COP149.82+0.76 (+0.51%) ▲|COST986.49+3.76 (+0.38%) ▲|CRM232.91-9.20 (-3.80%) ▼|CSCO109.78-0.51 (-0.46%) ▼|CVS91.12+1.17 (+1.30%) ▲|CVX231.09+1.89 (+0.82%) ▲|DE642.73+2.06 (+0.32%) ▲|DHR235.33+1.26 (+0.54%) ▲|DIS110.41+1.37 (+1.26%) ▲|DUK125.00+1.43 (+1.16%) ▲|EMR169.24+1.53 (+0.91%) ▲|FDX302.21-2.37 (-0.78%) ▼|GD366.11+11.76 (+3.32%) ▲|GE310.12+8.99 (+2.99%) ▲|GEV910.54+32.51 (+3.70%) ▲|GILD162.32+3.12 (+1.96%) ▲|GM83.90+1.42 (+1.72%) ▲|GOOG283.34-38.55 (-11.98%) ▼|GOOGL285.45-39.44 (-12.14%) ▼|GS934.98+9.81 (+1.06%) ▲|HD324.25+6.69 (+2.11%) ▲|HON217.91-1.35 (-0.62%) ▼|IBM253.97+0.75 (+0.30%) ▲|INTC93.11-2.42 (-2.53%) ▼|INTU330.88+2.69 (+0.82%) ▲|ISRG445.80+1.62 (+0.36%) ▲|JNJ274.67+3.63 (+1.34%) ▲|JPM345.18+5.88 (+1.73%) ▲|KO92.45+0.72 (+0.78%) ▲|LIN502.00-6.16 (-1.21%) ▼|LLY1,384.73+96.43 (+7.48%) ▲|LMT642.53+12.78 (+2.03%) ▲|LOW203.16+4.76 (+2.40%) ▲|LRCX258.03+4.21 (+1.66%) ▲|MA638.11+27.80 (+4.55%) ▲|MCD254.90+4.40 (+1.75%) ▲|MDLZ62.04+0.17 (+0.27%) ▲|MDT95.35+0.57 (+0.60%) ▲|META623.57+11.08 (+1.81%) ▲|MMM175.54+2.74 (+1.59%) ▲|MO75.79+2.80 (+3.83%) ▲|MRK146.79+5.86 (+4.15%) ▲|MS192.41+2.28 (+1.20%) ▲|MSFT524.28-6.73 (-1.27%) ▼|MU955.79-27.44 (-2.79%) ▼|NEE81.88+0.86 (+1.06%) ▲|NFLX62.09+0.10 (+0.15%) ▲|NKE38.22+1.07 (+2.88%) ▲|NOW113.63-36.50 (-24.31%) ▼|NVDA213.78-1.60 (-0.74%) ▼|ORCL140.26-4.29 (-2.96%) ▼|PEP133.00+0.37 (+0.28%) ▲|PFE29.69+0.24 (+0.80%) ▲|PG158.87+0.61 (+0.39%) ▲|PLTR195.59-1.22 (-0.62%) ▼|PM205.45+2.81 (+1.39%) ▲|QCOM181.31-1.66 (-0.91%) ▼|RTX199.85+4.01 (+2.05%) ▲|SBUX104.98+1.78 (+1.72%) ▲|SCHW89.71+0.95 (+1.06%) ▲|SO92.70+1.18 (+1.29%) ▲|SPG214.63+3.39 (+1.60%) ▲|T21.28+0.58 (+2.78%) ▲|TMO704.94+0.79 (+0.11%) ▲|TMUS149.97+1.89 (+1.27%) ▲|TSLA403.77-0.45 (-0.11%) ▼|TXN308.46-1.37 (-0.44%) ▼|UBER65.05-0.22 (-0.34%) ▼|UNH409.02+1.92 (+0.47%) ▲|UNP299.19+1.39 (+0.47%) ▲|UPS105.39-0.23 (-0.22%) ▼|USB60.45+0.85 (+1.43%) ▲|V411.26+10.66 (+2.66%) ▲|VZ44.01+0.83 (+1.91%) ▲|WFC85.15+1.48 (+1.76%) ▲|WMT120.18+1.41 (+1.19%) ▲|XOM183.60+1.58 (+0.87%) ▲|AAPL349.52+5.69 (+1.65%) ▲|ABBV291.18+5.19 (+1.81%) ▲|ABT103.62+0.98 (+0.95%) ▲|ACN243.66+0.26 (+0.10%) ▲|ADBE247.70-2.06 (-0.82%) ▼|AMAT416.25+0.25 (+0.06%) ▲|AMD568.12-10.32 (-1.78%) ▼|AMGN465.24+13.41 (+2.97%) ▲|AMT185.10+1.35 (+0.73%) ▲|AMZN246.26-8.34 (-3.28%) ▼|AVGO342.50-9.32 (-2.65%) ▼|AXP325.34+7.40 (+2.33%) ▲|BA170.33+3.19 (+1.91%) ▲|BAC51.76+0.91 (+1.78%) ▲|BKNG151.34+3.40 (+2.30%) ▲|BLK1,175.81+17.93 (+1.55%) ▲|BMY60.30-0.27 (-0.45%) ▼|BNY149.42+0.83 (+0.56%) ▲|BRK-B544.87+4.53 (+0.84%) ▲|C126.14+2.03 (+1.64%) ▲|CAT660.01-53.38 (-7.48%) ▼|CL91.89+0.20 (+0.21%) ▲|CMCSA21.82+0.25 (+1.16%) ▲|COF208.56+3.68 (+1.80%) ▲|COP149.82+0.76 (+0.51%) ▲|COST986.49+3.76 (+0.38%) ▲|CRM232.91-9.20 (-3.80%) ▼|CSCO109.78-0.51 (-0.46%) ▼|CVS91.12+1.17 (+1.30%) ▲|CVX231.09+1.89 (+0.82%) ▲|DE642.73+2.06 (+0.32%) ▲|DHR235.33+1.26 (+0.54%) ▲|DIS110.41+1.37 (+1.26%) ▲|DUK125.00+1.43 (+1.16%) ▲|EMR169.24+1.53 (+0.91%) ▲|FDX302.21-2.37 (-0.78%) ▼|GD366.11+11.76 (+3.32%) ▲|GE310.12+8.99 (+2.99%) ▲|GEV910.54+32.51 (+3.70%) ▲|GILD162.32+3.12 (+1.96%) ▲|GM83.90+1.42 (+1.72%) ▲|GOOG283.34-38.55 (-11.98%) ▼|GOOGL285.45-39.44 (-12.14%) ▼|GS934.98+9.81 (+1.06%) ▲|HD324.25+6.69 (+2.11%) ▲|HON217.91-1.35 (-0.62%) ▼|IBM253.97+0.75 (+0.30%) ▲|INTC93.11-2.42 (-2.53%) ▼|INTU330.88+2.69 (+0.82%) ▲|ISRG445.80+1.62 (+0.36%) ▲|JNJ274.67+3.63 (+1.34%) ▲|JPM345.18+5.88 (+1.73%) ▲|KO92.45+0.72 (+0.78%) ▲|LIN502.00-6.16 (-1.21%) ▼|LLY1,384.73+96.43 (+7.48%) ▲|LMT642.53+12.78 (+2.03%) ▲|LOW203.16+4.76 (+2.40%) ▲|LRCX258.03+4.21 (+1.66%) ▲|MA638.11+27.80 (+4.55%) ▲|MCD254.90+4.40 (+1.75%) ▲|MDLZ62.04+0.17 (+0.27%) ▲|MDT95.35+0.57 (+0.60%) ▲|META623.57+11.08 (+1.81%) ▲|MMM175.54+2.74 (+1.59%) ▲|MO75.79+2.80 (+3.83%) ▲|MRK146.79+5.86 (+4.15%) ▲|MS192.41+2.28 (+1.20%) ▲|MSFT524.28-6.73 (-1.27%) ▼|MU955.79-27.44 (-2.79%) ▼|NEE81.88+0.86 (+1.06%) ▲|NFLX62.09+0.10 (+0.15%) ▲|NKE38.22+1.07 (+2.88%) ▲|NOW113.63-36.50 (-24.31%) ▼|NVDA213.78-1.60 (-0.74%) ▼|ORCL140.26-4.29 (-2.96%) ▼|PEP133.00+0.37 (+0.28%) ▲|PFE29.69+0.24 (+0.80%) ▲|PG158.87+0.61 (+0.39%) ▲|PLTR195.59-1.22 (-0.62%) ▼|PM205.45+2.81 (+1.39%) ▲|QCOM181.31-1.66 (-0.91%) ▼|RTX199.85+4.01 (+2.05%) ▲|SBUX104.98+1.78 (+1.72%) ▲|SCHW89.71+0.95 (+1.06%) ▲|SO92.70+1.18 (+1.29%) ▲|SPG214.63+3.39 (+1.60%) ▲|T21.28+0.58 (+2.78%) ▲|TMO704.94+0.79 (+0.11%) ▲|TMUS149.97+1.89 (+1.27%) ▲|TSLA403.77-0.45 (-0.11%) ▼|TXN308.46-1.37 (-0.44%) ▼|UBER65.05-0.22 (-0.34%) ▼|UNH409.02+1.92 (+0.47%) ▲|UNP299.19+1.39 (+0.47%) ▲|UPS105.39-0.23 (-0.22%) ▼|USB60.45+0.85 (+1.43%) ▲|V411.26+10.66 (+2.66%) ▲|VZ44.01+0.83 (+1.91%) ▲|WFC85.15+1.48 (+1.76%) ▲|WMT120.18+1.41 (+1.19%) ▲|XOM183.60+1.58 (+0.87%) ▲|

17.5 C

New York

Thursday, October 29, 2026

National Sleep Foundation Projects More Than 145 Million U.S. Drivers Have Driven Impaired by Sleepiness, 4 in 10 Can’t Recognize the Warning Signs of...

ACCP Position Statement: “ACCP Call to Action–The Need for Vaccine Education”

Society Awards Unveils a New Brand Identity for the Luxury Awards Category It Created

Tag: period

DMRC INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Digimarc Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

NEW YORK, June 22, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Digimarc Corporation (“Digimarc” or “the Company”) (NASDAQ: DMRC) and certain of its officers.

Mim8 prophylaxis treatment shown to be well-tolerated when switching from emicizumab in people with hemophilia A in new phase 3 data presented at the...

New FRONTIER5 results show a direct switch to investigational Mim8 (denecimig) prophylaxis treatment from emicizumab, without the need for a washout period, was well-tolerated...

Novo Nordisk A/S: Mim8 prophylaxis treatment shown to be well-tolerated when switching from emicizumab in people with haemophilia A in new phase 3 data...

Bagsværd, Denmark, 22 June 2025 – Novo Nordisk today presented results from the phase 3b FRONTIER5 trial showing that a direct switch to investigational Mim8 (denecimig) prophylaxis from emicizumab treatment, without a washout period or Mim8 loading dose, was well-tolerated with no safety concerns in adults and adolescents living with haemophilia A, with or without inhibitors¹. Additionally, a FRONTIER5 Patient-Reported Outcomes (PROs) assessment found the Mim8 pen-injector easy to use, with an overall strong user preference for the pen-injector compared to the previous emicizumab injection system^2,3. The results were presented at the International Society on Thrombosis and Haemostasis (ISTH) Congress in Washington, D.C.

Lilly’s once-weekly insulin efsitora alfa demonstrated A1C reduction and a safety profile consistent with daily insulin in multiple Phase 3 trials

Results from the fixed-dose QWINT-1 study, along with the QWINT-3 and QWINT-4 studies, reinforce efsitora's potential to simplify insulin management with weekly dosing Lilly plans...